Characteristics of Patients with Non-Malignant Pleural Effusion

Abstract

Introduction Non-malignant pleural effusions (NMPEs) are a common clinical finding associated with significant morbidity and mortality, yet they often receive less attention than their malignant counterparts. The diverse etiologies and prognostic implications of NMPEs pose considerable diagnostic and management challenges. This literature review synthesizes recent evidence to delineate the characteristics, underlying causes, and clinical outcomes of patients with NMPEs.

Methods This comprehensive literature review analyzes and synthesizes findings from five key articles published between 2014 and 2024. The analysis includes systematic and narrative reviews examining mortality rates, pathogenesis, and the specific clinical contexts of infectious and cardiac-related pleural effusions.

Results The literature reveals that NMPEs account for the majority (70–80%) of all pleural effusions. The presence of an effusion is a significant predictor of mortality, with nearly one-third of patients dying within one year of hospital admission. Congestive heart failure is the most frequent underlying cause of NMPEs. Pleural infections are another major cause, with high incidence rates and a 12-month mortality rate of 32%. A key finding is that approximately 30% of these infections occur without evident pneumonia, complicating diagnosis. Critically, there is a lack of specific clinical guidelines for managing NMPEs.

Discussion The synthesized evidence strongly suggests that NMPEs should be viewed as critical indicators of severe underlying disease, not benign secondary findings. The high mortality associated with these effusions underscores the inadequacy of current management paradigms. The absence of specific guidelines for NMPEs, the most common type of effusion, represents a major gap in clinical practice, forcing clinicians to often model treatment on malignant effusion protocols.

Conclusion There is an urgent need for heightened clinical awareness and the development of evidence-based management guidelines specifically for NMPEs. A proactive approach, including thorough diagnostic investigation into underlying causes like cardiac failure and infection, is essential to mitigate the high morbidity and mortality associated with these conditions.